Small companies: Pitch your technology at the National Meeting; Deadline April 7
Collaborate on innovative manufacturing platforms and technologies that accelerate the development and manufacture of life-saving medicines and medical countermeasures, enhance national economic security, and support response to biothreats
Help companies de-risk the adoption and implementation of new technologies and approaches for development and manufacturing
Strengthen the U.S. economy by cultivating a world-leading biopharmaceutical workforce that meets the industry’s needs through novel training and education programs
Udit Batra, President & CEO, Waters
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
This Viral Vector Program Request for Applications (RFA) aims to fund a team to participate in its the Program’s initiative on optimizing long-read next generation sequencing (NGS) capabilities.
NEW DEADLINE: The submission deadline is April 4, 2025, at 5 pm ET.
NIIMBL is planning a special session at the 2025 National Meeting. The meeting is scheduled to be held in Washington DC from June 24-27, 2025. The special session will be a pitch session (i.e. “Shark Tank”-style) where three organizations will be invited to pitch their promising technology in front of a panel of experts. Each of the three organizations will be given 30 minutes total time consisting of a short introductory statement followed by panel question and answer. At the end of the session, a process will be used to select a winning pitch. Because only three organizations will be given an opportunity to present, this RFI is being used to help identify interested parties. The primary intended and expected type of organization would be small companies (e.g. Tier 3 industry members) with promising biopharmaceutical manufacturing-related technology. However, an academic member planning to pursue commercialization of a new technology or a large company with a promising new technology are welcome to submit information but may not be prioritized over small businesses.
Purpose of this RFI:
The submission deadline is April 7, 2025, at 5 pm ET.
RFP 8.1 includes global health, technology development, and workforce development topics. It is open to current NIIMBL members and to new members by the close of the full proposal deadline.
Submission deadline is September 30, 2024.
RFP 7.1 includes both technology development and workforce development topics, with a funding amount of up to $4 million. It is open to current NIIMBL members and to new members by the close of the full proposal deadline.
Project Call 7.1 closed on December 7, 2023. Submissions are now in review.
RFI 2024.1 – Universal Connectivity for In-Process Analytics in Biopharmaceutical Manufacturing – aims to gather insights and ideas regarding the development of a Universal Connectivity System for at-line/inline analytical instrumentation. This initiative looks to support NIIMBL's Big Data program in biomanufacturing.
NIIMBL invites submissions from interested parties to share information on potential solutions for a Universal Connectivity System. This system is envisioned as an OT/IT core to facilitate seamless data integration and advanced analytics within biomanufacturing processes, thus enabling data-driven decision-making and process optimization.
RFI 2024.2 – Hybrid Model Federated Learning – seeks innovative approaches that combine Federated Learning with hybrid models (combining Physics-Based and AI/ML data-driven methodologies) specifically tailored for biopharmaceutical manufacturing processes. This request aims to gather insights and concepts for achieving integration and operationalization of these models in a practical, industry-relevant context. By fostering collaboration among a wide range of stakeholders, we aim to enhance prediction accuracy of Hybrid Models for biopharmaceutical process predictions using Federated Learning and other Privacy Preserving Computing approaches. This initiative seeks to train a centralized model using community data while maintaining data privacy.
This RFI is a preliminary step to gauge interest and gather insights which may shape future studies or funding opportunities in Hybrid Model Federated Learning. This RFI is not a solicitation for funding proposals. We encourage contributions from all interested parties to become integral parts of this innovative endeavor.
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
Viral Vector RFA2025.1
This Viral Vector Program Request for Applications (RFA) aims to fund a team to participate in its the Program’s initiative on optimizing long-read next generation sequencing (NGS) capabilities.
NEW DEADLINE: The submission deadline is April 4, 2025, at 5 pm ET.
RFI 2025.1: "Shark Tank" Pitches National Meeting
NIIMBL is planning a special session at the 2025 National Meeting. The meeting is scheduled to be held in Washington DC from June 24-27, 2025. The special session will be a pitch session (i.e. “Shark Tank”-style) where three organizations will be invited to pitch their promising technology in front of a panel of experts. Each of the three organizations will be given 30 minutes total time consisting of a short introductory statement followed by panel question and answer. At the end of the session, a process will be used to select a winning pitch. Because only three organizations will be given an opportunity to present, this RFI is being used to help identify interested parties. The primary intended and expected type of organization would be small companies (e.g. Tier 3 industry members) with promising biopharmaceutical manufacturing-related technology. However, an academic member planning to pursue commercialization of a new technology or a large company with a promising new technology are welcome to submit information but may not be prioritized over small businesses.
Purpose of this RFI:
The submission deadline is April 7, 2025, at 5 pm ET.
RFP 8.1
RFP 8.1 includes global health, technology development, and workforce development topics. It is open to current NIIMBL members and to new members by the close of the full proposal deadline.
Submission deadline is September 30, 2024.
RFP 7.1
RFP 7.1 includes both technology development and workforce development topics, with a funding amount of up to $4 million. It is open to current NIIMBL members and to new members by the close of the full proposal deadline.
Project Call 7.1 closed on December 7, 2023. Submissions are now in review.
RFI 2024.1: Universal Connectivity
RFI 2024.1 – Universal Connectivity for In-Process Analytics in Biopharmaceutical Manufacturing – aims to gather insights and ideas regarding the development of a Universal Connectivity System for at-line/inline analytical instrumentation. This initiative looks to support NIIMBL's Big Data program in biomanufacturing.
NIIMBL invites submissions from interested parties to share information on potential solutions for a Universal Connectivity System. This system is envisioned as an OT/IT core to facilitate seamless data integration and advanced analytics within biomanufacturing processes, thus enabling data-driven decision-making and process optimization.
RFI 2024.2: Hybrid Model
RFI 2024.2 – Hybrid Model Federated Learning – seeks innovative approaches that combine Federated Learning with hybrid models (combining Physics-Based and AI/ML data-driven methodologies) specifically tailored for biopharmaceutical manufacturing processes. This request aims to gather insights and concepts for achieving integration and operationalization of these models in a practical, industry-relevant context. By fostering collaboration among a wide range of stakeholders, we aim to enhance prediction accuracy of Hybrid Models for biopharmaceutical process predictions using Federated Learning and other Privacy Preserving Computing approaches. This initiative seeks to train a centralized model using community data while maintaining data privacy.
This RFI is a preliminary step to gauge interest and gather insights which may shape future studies or funding opportunities in Hybrid Model Federated Learning. This RFI is not a solicitation for funding proposals. We encourage contributions from all interested parties to become integral parts of this innovative endeavor.
RFA: Faculty Fellows
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
Our members are stakeholders from across the biopharmaceutical manufacturing ecosystem, including large and small companies, academic institutions, and nonprofits.
Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.
June 30, 2023
The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:
Biopharmaceuticals are medicines and medical countermeasures that save, sustain, and improve lives. They:
Mike Kress, Sr. Vice President Development Sciences and Clinical Supply,
Merck & Co., Inc.
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
